Medical Affairs Certificate Program Module C – Scientific excellence
A deep understanding of scientific rigor enables the effective localization of international data generation projects, ensuring that global findings are accurately adapted to the Swiss context. Conducting high-quality local studies is essential for generating robust data in Switzerland that meets publication standards, reinforcing the country’s contribution to global medical knowledge.
Moreover, this expertise is crucial in the seamless transfer of science into patient care, where insights from clinical research are translated into tangible health benefits. Therefore, a dedicated training course on scientific excellence is indispensable for empowering Medical Affairs professionals to excel in these responsibilities.
- Scientific knowledge and understanding
- Data generation in Switzerland
- Transfer of science into patient care
After completion of this module, the participants will have the following …
- Knowledge and understanding
- Clinical development process & post-approval research -Swiss specific aspects of company-internal headquarter processes
- Design and conduct of data generation projects in Switzerland
- Legal basics in human research
- Swissethics / Swissmedic
- Stakeholder / patients / public involvement & GCP
- Publication of generated data
- And are able to apply in their job
- Shaping the role of a local MA organization in the clinical development process & post-approval research
- Localization of international data generation / local studies
- Generating data in Switzerland that can be published
- Transfer of science into patient care - "from science to patient care"
- The following related topics/skills are also cross-referenced to other modules
- Presentation of complex data, module B Medical communication & presentation
- Swiss regulatory environment, module A Swiss healthcare system
Medical Lead Alpine
Alexion Pharma GmbH
Country Medical Affairs Director Switzerland
Gilead Sciences Switzerland Sàrl
Study & Site Operations (SSO) Country Manager Switzerland
Novartis Pharma (Schweiz) AG
Program Manager Patient Advisory Board
Swiss Cancer Institute
Director Medical Customer Engagement
Roche Pharma (Schweiz) AG
CEO
Wels - Omnino Medico
Lead Early Medical
Novartis Pharma (Schweiz) AG
Rechtsanwältin und Partnerin
Pharmalex GmbH
Medical Affairs Certificate Program Module C – Scientific excellence
Register hereDate
Part 1:
Tuesday, January 26, 2027
09.00
- 17.30
Seminar
Part 2:
Thursday, January 28, 2027
08.30
- 12.30
Live webinar
Language
English
Course type
Seminar
Location
shqa
Hirschmattstrasse 1, 6003 Luzern
Cost per person (excl. VAT)
CHF 1'470 .– (for shqa members)
CHF 2'220 .– (for non-members)
Inclouding confirmation of participation and course documents
A practice-oriented, cross-company Medical Affairs education is rare — SHQA is filling this gap. The certificate program content provides me with hands-on examples and strategies for my daily job. Furthermore, the interactive sessions with expert instructors fostered a collaborative learning environment that I greatly appreciated.
Sandra Maamari, Medical Advisor / Bayer (Schweiz) AG
Participant Seminar "Medical Affairs Certificate Program"